Insulin Aspart (NovoRapid) from Canada
Fast-acting insulin analogue with aspartic acid substitution, rDNA origin, used for mealtime glycemic control. Classified in 2937.12.00.00 as insulin structural analogue per heading description for chain-modified polypeptides used as hormones.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include batch-specific certificates of analysis showing >97% purity and correct sequence
• Refrigerated transport with validated packaging; temperature excursions void bioactivity
• Distinguish bulk API from finished products to maintain Chapter 29 classification